Home
  • Project
    • Concept
    • Work plan
  • Consortium
  • Patients
    • Study 1 – HCM
    • Study 2 – BERT
  • Media
  • Publications
  • Newsletter

Consortium

  • Radboud University Medical Center (RUMC)
  • University of Oxford (UOXF)
  • Public Health England (PHE)
  • Institut Pasteur de Lille (IPL)
  • Trinity College Dublin (TCD)
  • University of Turku (UTU)
  • Commissariat à l’énergie atomique et aux energies alternatives (CEA)
  • National Institute for Public Health and the Environment (RIVM)
  • Institute of Microbiology of the CAS, v. v. i. (IMIC)
  • University of Basel (UNIBAS)
  • University of Bath (UB)
  • Leiden University Medical Center (LUMC)
  • University of Salamanca (USAL)
  • Université Libre de Bruxelles (ULB)
  • Hospice Cantonaux (CHUV)
  • University of Southampton (US)
  • Q-Biologicals NV (QB)
  • European Research and Project Office GmbH (EURICE)
  • Sanofi (Sanofi)
  • GSK Vaccines (GSK)
  • London School of Hygiene and Tropical Medicine (LSHTM)

EUIMIEFPIABMGF

PERISCOPE has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115910.
This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and BMGF.

  • Contact
  • Imprint
  • Privacy